Mediators of Cellular Immunity in Man
The purpose of this introductory paper is twofold: (1) to summarize experimental work that has led to the new concepts of the mediators of cellular immunity; and (2) to show how this concept is being applied to problems of clinical immunology.
Theoretical and Semantic Basis Perhaps the most striking advance in immunobiology has been the realization that, whereas lymphocyte activity ultimately underlies the immune response, its cellular and humoral manifestations are governed by distinct yet cooperating compartments of the lymphoid system.
Thus there is much evidence that immune induction is regulated by cellular co-operation within the lymphoid system and that peripheral manifestations of the immune response frequently result from interactions between its cell-mediated and antibody-mediated components. Current theories of adaptive immunity suggest that these interacting mechanisms regulate immunological responses based upon genomic flexibility ('hypermutability') of uncommitted lymphocytes together with stabilization ('phenotypic restriction') of immune pattern generated by antigenselected 'sensitized' lymphocytes (Burnet 1969) .
In practical terms it is clear that events resulting from interaction of sensitized lymphocytes with specific antigen depend largely on the biological and immunological environment in which this interaction is taking place. In the animal this can result in the inflammation of delayed hypersensitivity or the rejection of tissue allografts; or the enhanced elimination of those infective agents Green et al. (1969) which can reside inside macrophages or other cells. In culture the term 'cellular hypersensitivity' is used to refer to the observable effects of antigenon lymphoid cell populations: forexample, transformation of lymphocytes or inhibition of macrophage or leukocyte migration. Similarly the term 'cellular immunity' refers to the aggressive effects of lymphoid cell populations on cellular or microbial antigen: for example, the cytotoxic effects of sensitized lymphocytes on antigenbearing tissue cells, or the microbicidal activities of'immune' macrophages.
Cytokinetic features of cell-mediated immune reactions have suggested that cellular interactions play an important part in their mechanism (Table  1) . These considerations naturally lead to the possibility that co-operator molecules are generally involved in the expression ofthe cell-mediated immune response; that such factors may facilitate co-operation between sensitized lymphocytes and other lymphocytes or macrophages in the response of sensitized lymphoid cell populationsto antigen; and that these factors may therefore play an important part in regulation of the cell-mediated immune response. During the last few years experimental methods have been developed for the recognition and assay of such biologically active 'lymphokine' factors; and it is the development of this new field and its extension to man that has given rise to the subject of this discussion.
Experimental Production ofLymphokine Factors
Clear-cut experiments utilize guinea-pigs with delayed hypersensitivity induced by sensitization with antigens (e.g. bovine y-globulin) in Freund's complete adjuvant. Lymphocyte populations from such animals are divided into two aliquots; a first is cultured with sensitizing antigen for 1-3 days, after which the cells are removed and the supernatant is kept. A second aliquot is cultured without antigen under otherwise similar conditions; at the end of the cultute period the cells are removed and specific antigen is added to the supematant in the same concentration present in the first culture aliquot. In this way both kinds of supernatant contain the same amount of antigen; however the first (P, preincubated) supernatant is derived from interaction of lymphoid cells and antigen, whereas in the second (R, reconstituted) supernatant, antigen is added only after the lymphoid cells have been removed (Dumonde et al. 1969) . Representative experiments consist in determining whether these P supernatants have biologically active factors when compared with their reconstituted R controls in test systems relevant to the phenomena of cell-mediated immunity (Table 2) .
When these soluble factors are bioassayed in the guinea-pig by the differences between the P's and the R's, they are found to be induced only by immunological reaction between sensitized lym-Section of Clinical immunology and Allergy 901 phoid cells and specific immunizing antigen. In the guinea-pig at least six of these factors differ from classical antibody and from immune complexes; for their molecular weight lies between 30,000 and 80,000 and they are unprecipitated by half-saturated ammonium sulphate. The migration inhibition factor (MIF) behaves as a-protein of molecular weight 60,000-80,000 which can be freed of antigen and of serum protein by immunoadsorption and salt fractionation; such material inhibits macrophage migration in a concentration of 1-10 pg/ml; 1010 lymphocytes are needed to generate 1 mg of it in twenty-four hours of culture . In proposing the generic term 'lymphokine' to describe this group of non-antibody factors generated by antigenic activation of lymphocytes, we have suggested that these lymphokine factors represent the very molecules by which sensitized lymphocytes take action in both the expression and regulation of the immunological response (Dumonde et al. 1969 ). That these factors, when injected directly into the afferent lymphatics, induce lymph node paracortical hyperplasia provides one morphological justification for the use of the generic term (Kelly et al. 1970) . It remains to be determined whether the wealth of biological activities (Table 2 ) are due to the same or to different macromolecular entities.
Generation of Soluble Factors
by Human Lymphocytes Reports during the last two years have revealed that three of the factors (migration inhibition, cytotoxic and mitogenic) can be generated by antigen-activated human lymphocytes in delayed hypersensitivity (Thor et al. 1968 , Kolb & Granger 1968 , Maini et al. 1969 . Our approach has been to purify human peripheral lymphocytes from individuals with known forms of hypersensitivity to tuberculin PPD, grass pollen or fungal antigens; and to test preincubated and reconstituted lymphocyte supernatants in parallel for one or more of four biological activities.
Mitogenic activity is assayed by the comparative ability of supernatants to transform fresh lymphocytes obtained either from a nonhypersensitive subject, or from the same donor on a second occasion. Migration activity of human supernatants is tested by their ability to inhibit the migration of guinea-pig macrophages or of human or guinea-pig polymorphs from cell explants packed in capillary tubes. Cytopathic activity is tested by the release of 5 1Cr from monolayers of chromium-labelled mouse fibroblasts which have been cultured in the lymphocyte supernatants. Inflammatory activity of human lymphocyte supernatants is tested by their intradermal injection into the guinea-pig and by measuring the egress of iodine-labelled plasma protein and chromium-labelled erythrocytes into the inflammatory regions. We then utilize gel filtration and salt precipitation to determine the relative role of immune complexes and lymphokine factors in these biological activities of the lymphocyte supernatants. This approach in man is designed to establish the clinical and biochemical significance of in vitro tests of cellular hypersensitivity and cellular immunity, in order to permit their interpretation when applied to immunological situations of uncertain pathogenesis.
By fractionation of culture fluiids from
Mantoux-positive lymphocytes we find that both the mitogenic and migration inhibition activities behave like animal lymphokine factors in that they are not precipitated by half-saturated ammonium sulphate and that they are both retarded on G-100 Sephadex (Maini et al. 1970 ). Kolb & Granger (1968) have reported similar chromotographic behaviour of the cytotoxic 30 factor. In tuberculin sensitivity, these three factors are therefore different from classical antibody and from immune complexes, which suggests that the lymphokine concept extends to man. In grass pollen allergy we found that whereas 90% of the patients generated a lymphocyte mitogenic factor, only 30 % of these were able to generate a migration inhibition factor; retrospective inquiry revealed that the latter group had either received desensitization therapy or showed only minor forms of clinical allergy (Maini et al. 1970 ). It may be that stimulation of cell-mediated immunity in grass pollen allergy results in cellular co-operation for production of effective amounts of blocking antibody, a hypothesis which we are proceeding to test. We can anticipate that biochemical study of the lymphocyte factors produced by different categories of allergic patients will reveal what proportion of their cellular activity is mediated by immune complexes on the one hand, and by lymphokine factors on the other.
Biological and Clinical Significance of Mediators ofCellular Immune Reactions
In the development of a new field of biological enquiry it is tempting to suggest that its features contribute to much that was formerly ill understood; for example, Table 3 summarizes directions in which possible roles for lymphokine factors in the immunology and physiology of the lymphoid system are being sought. A hypothesis which seeks to embrace immunological phenomena ranging from the maintenance of lymphocyte hypermutability to the expression of grass pollen allergy runs the risk of appearing overspeculative. With this reservation we suggest that lymphokine factors are involved both in the peripheral expression of cell-mediated immunity and in regulation of the immunological response; that their significance may be fundamental to mechanisms of cellular surveillance; and that in evolution, their origin may have run parallel with the development of adaptive immunity.
In man it is now feasible to analyse the mediators of cellular hypersensitivity and immunity, by extension of work currently undertaken in laboratory animals, as a field of clinical investigation that has emerged from the stage of technical development (Table 4 ). In practice, however, we may have to accept two principal reservations.
Firstly, we are generally committed to dealing with peripheral blood for clinical purposes and we can expect species differences in the representation of the two major lymphocyte compartments in the circulation of animals and man. Secondly, we may anticipate that the mixed forms of humoral and cell-mediated immunity that accompany human disease may lead to analytical results Table 4 Study of cellular immune mechanisms in man Documentation of cellular reactivity to antigen in defined states of clinical hypersensitivity: tests of lymphocyte transformation, macrophage/leukocyte migration, and lymphocyte cytotoxicity Correlation in breadth and depth with other clinical and investigative situations: detection of allograft and tumour immunity, study of acute and chronic microbial infection, assessment of autoimmunity and immunological deficiency states Delineation of role of immune complexes and lymphokine factors in apparent reactions of cellular hypersensitivity and cellular immunity Purification, isolation and-action of lymphokine mediators in man Design of promotors and antagonists of lymphokine activities as a basis for controlling cellular immune mechanisms in man that may not run parallel to those derived from experimental animals. The three principal tests which can now be offered are those of lymphocyte transformation, macrophage or leukocyte migration, and lymphocyte-cytbtoxicity; and having established their behaviour in defined states of clinical hypersensitivity it will be possible to interpret them in clinical situations where immunological mechanisms are less well defined. The exploitation of this field will be a complex and fascinating undertaking; and with cautious optimism might even yield a predictive basis for controlling the immunological respoiise in man. Perhaps it is at least safe to predict that the development of this field of discussion will figure prominently in the clinical and immunological literature of the 1970s.
